These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24489960)

  • 21. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
    Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First IKBKG gene mutation study in Serbian incontinentia pigmenti patients.
    Minić S; Trpinac D; Gabriel H; Gencik M; Obradović M
    Srp Arh Celok Lek; 2013; 141(7-8):490-4. PubMed ID: 24073555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incontinentia pigmenti: a rare pathology with complex rehabilitative aspects.
    Lioce E; Milani P; Bistolfi A; Capacchione P; Nascimbeni A; Massazza G
    Disabil Rehabil; 2014; 36(21):1830-3. PubMed ID: 24383470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incontinentia pigmenti, an x-linked dominant disorder, in a 2-year-old boy with Klinefelter syndrome.
    Williams A; Chandrashekar L; Srivastava VM; Thomas M; Horo S; George R
    Indian J Pathol Microbiol; 2017; 60(3):424-426. PubMed ID: 28937389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion.
    Bardaro T; Falco G; Sparago A; Mercadante V; Gean Molins E; Tarantino E; Ursini MV; D'Urso M
    Hum Mutat; 2003 Jan; 21(1):8-11. PubMed ID: 12497627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncovering incontinentia pigmenti: From DNA sequence to pathophysiology.
    How KN; Leong HJY; Pramono ZAD; Leong KF; Lai ZW; Yap WH
    Front Pediatr; 2022; 10():900606. PubMed ID: 36147820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incontinentia pigmenti in an XY boy: case report and review of the literature.
    Mullan E; Barbarian M; Trakadis Y; Moroz B
    J Cutan Med Surg; 2014; 18(2):119-22. PubMed ID: 24636437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variable clinical expression of familial Incontinentia Pigmenti syndrome - presentation of three cases].
    Kutkowska-Kaźmierczak A; Obersztyn E; Bonnefont JP; Rosińska-Borkowska D; Mazurczak T; Sobczyńska-Tomaszewska A; Mazurczak T
    Med Wieku Rozwoj; 2008; 12(3):748-53. PubMed ID: 19305025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incontinentia pigmenti and hypomelanosis of Ito.
    Bodemer C
    Handb Clin Neurol; 2013; 111():341-7. PubMed ID: 23622185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of the
    Minić S; Cerovac N; Novaković I; Gazikalović S; Popadić S; Trpinac D
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with Incontinentia Pigmenti.
    Fusco F; Paciolla M; Pescatore A; Lioi MB; Ayuso C; Faravelli F; Gentile M; Zollino M; D'Urso M; Miano MG; Ursini MV
    Hum Mutat; 2009 Sep; 30(9):1284-91. PubMed ID: 19603533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incontinentia Pigmenti with Persistent Hypercalcemia: Case Report.
    Adashek J; Mu W; Francis J; Cohen B; Pruette C; Grossberg A; Bodurtha J
    Pediatr Dermatol; 2016 Sep; 33(5):e315-7. PubMed ID: 27412134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incontinentia pigmenti with ultrastructurally disordered leucocytes.
    Minić S; Trpinac D; Obradović M; Novotny GE; Gabriel HD; Kuhn M
    J Clin Pathol; 2010 Jul; 63(7):657-9. PubMed ID: 20591917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incontinentia pigmenti: case report].
    Portaleone D; Taroni E; Micheli S; Moioli M; Pedrazzini A; Carnelli V
    Pediatr Med Chir; 2007; 29(6):343-5. PubMed ID: 18410066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
    Berlin AL; Paller AS; Chan LS
    J Am Acad Dermatol; 2002 Aug; 47(2):169-87; quiz 188-90. PubMed ID: 12140463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
    Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
    Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.
    Aradhya S; Woffendin H; Jakins T; Bardaro T; Esposito T; Smahi A; Shaw C; Levy M; Munnich A; D'Urso M; Lewis RA; Kenwrick S; Nelson DL
    Hum Mol Genet; 2001 Sep; 10(19):2171-9. PubMed ID: 11590134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of central nervous system anomalies in incontinentia pigmenti.
    Minić S; Trpinac D; Obradović M
    Orphanet J Rare Dis; 2013 Feb; 8():25. PubMed ID: 23406512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.